الخلايا الجذعية الجنينية

Embryonic stem (ES) cells are undifferentiated cells derived from the inner cell mass of a blastocyst, a three to five day old embryo. In humans, they are typically obtained from donated embryos left over from in vitro fertilization (IVF). These cells are pluripotent, meaning they can produce any cell type in the body, making them valuable for research and medical applications.

Embryonic stem cells are pluripotent because they can differentiate into all the different cell types found in the body, from blood to brain cells. This unique capability arises from their undifferentiated state and their origin in the early embryo. Their pluripotency gives them tremendous potential in science and medicine for generating specific cell types needed for research or therapy.

Scientists manipulate culture conditions to direct embryonic stem cell differentiation into specific cell types. They can change the surface of the culture dish, add specific growth factors to the culture medium, or genetically modify the cells. These methods allow researchers to generate desired cell types including blood, nerve, heart, bone, liver, and pancreas cells for research and therapeutic use.

Regenerative medicine uses embryonic stem cells to create living, functional tissues that replace dead, diseased, or malfunctioning ones. Because ES cells can differentiate into any cell type, they can generate replacement tissues for various organs and tissues. Clinical studies have shown promising results, including paralyzed patients regaining movement after receiving ES-derived nervous system cells.

Yes, embryonic stem cells can divide indefinitely when grown in culture, producing new stem cells continuously. This property allows researchers to create ES cell lines—stable populations of cells that can be maintained and expanded over long periods. This unlimited proliferation capacity makes ES cells particularly valuable for large-scale research and therapeutic applications.

Embryonic stem cells could potentially treat conditions where specific cell types are destroyed or lost due to disease or damage. For example, Type One diabetes could be addressed by generating insulin-producing pancreatic cells from ES cells. Additionally, ES cells can replace damaged nerve cells in spinal cord injuries and other tissues affected by degenerative diseases or injury.

Embryonic stem cells serve multiple research purposes beyond regenerative medicine. They enable scientists to study early events in human development, which is otherwise difficult to observe directly. ES cells also provide a source of specific cell types for drug testing and other scientific research, helping researchers understand disease mechanisms and evaluate potential therapeutic compounds.